Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve Financial Results

Date: 19October 2026 To To BSE Limited National StockExchange of India Limited Phiroze JeejeebhoyTowers Exchange Plaza Dalal Street Bandra KurlaComplex, Bandra(E) Mumbai –400001 Mumbai –400051 SecurityCode: 540596 SecurityCode: ERIS SUBJECT: BOARDMEETING INTIMATION Dear Sir/Madam, NOTICE IS HEREBY given that a Meeting of the Board of Directors of Eris Lifesciences Limited (“the Company”) is scheduled on Monday, October 26, 2026, to, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended September 30, 2026. Further, as informed by us vide letter dated September 28, 2026, the trading window has been already closed from October 01, 2026, and will remain closed till 48 hours after the declaration of financial results of the Company pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015, and Policy on ‘Code of Conduct to Regulate, Monitor and Report Trading by its Designated Persons and immediate relatives of Designated Persons of the Company’. Thanking You, For Eris Lifesciences Limited MilindTalegaonkar Company Secretary &ComplianceOfficer ICSI Mem. No: A26493